Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials Jean-Philippe JacquinStephen JonesSilvy Laporte Review 24 January 2012 Pages: 903 - 913
A prospective study of breast lymphedema: frequency, symptoms, and quality of life Amy C. DegnimJoyce MillerAndrea L. Cheville Review 14 March 2012 Pages: 915 - 922
Accuracy of quantitative ultrasound elastography for differentiation of malignant and benign breast abnormalities: a meta-analysis Gelareh SadighRuth C. CarlosBen A. Dwamena Review 15 March 2012 Pages: 923 - 931
Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients Heidi SchwarzenbachKarin Milde-LangoschKlaus Pantel Preclinical Study 19 February 2012 Pages: 933 - 941
Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer Neng WangZhi-Yu WangJian-Ping Chen Preclinical Study Open access 21 February 2012 Pages: 943 - 955
Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis Xiaosong ChenYing YuanKunwei Shen Preclinical Study 28 February 2012 Pages: 957 - 967
Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors Jinjia ChangMeihua SuiWeimin Fan Preclinical study 29 February 2012 Pages: 969 - 980
Atypical ezrin localization as a marker of locally advanced breast cancer Alan A. ArslanDeborah SilveraRobert J. Schneider Preclinical Study 14 March 2012 Pages: 981 - 988
Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway Li-Ching ChenShih-Hsin TuYuan-Soon Ho Preclinical Study 21 March 2012 Pages: 989 - 1004
Germline copy number variants are not associated with globally acquired copy number changes in familial breast tumours Logan C. WalkerLutz KrauseNic Waddell Preclinical study Open access 21 March 2012 Pages: 1005 - 1011
Non-invasive quantification of tumor vascular architecture during docetaxel-chemotherapy Karine MahéoStephan ChevalierCaroline Goupille Preclinical Study 22 March 2012 Pages: 1013 - 1025
Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation Matthew J. SikoraViktoriya StrumbaJames M. Rae Preclinical Study 29 March 2012 Pages: 1027 - 1039
Strigolactones: a novel class of phytohormones that inhibit the growth and survival of breast cancer cells and breast cancer stem-like enriched mammosphere cells C. B. PollockH. KoltaiR. I. Yarden Preclinical Study 29 March 2012 Pages: 1041 - 1055
Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer Haiyan LiJun LinXiaochun Bai Preclinical Study 04 April 2012 Pages: 1057 - 1066
Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration Su-Hyeong KimAnuradha SehrawatShivendra V. Singh Preclinical Study 04 April 2012 Pages: 1067 - 1079
MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer Chun-Wen ChengHsiao-Wei WangChen-Yang Shen Preclinical Study 04 April 2012 Pages: 1081 - 1093
Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance Yi-ling YangYu FanLi Fu Preclinical Study 05 April 2012 Pages: 1095 - 1102
Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study Anneke Q. van HoeselCornelis J. H. van de VeldeDave S. B. Hoon Preclinical Study 05 April 2012 Pages: 1103 - 1114
Nomogram for predicting positive resection margins after breast-conserving surgery Hee-Chul ShinWonshik HanDong-Young Noh Clinical trial 13 June 2012 Pages: 1115 - 1123
Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use? Jeffrey G. SchneiderDanny N. Khalil Clinical Trial 22 June 2012 Pages: 1125 - 1132
Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy Hyeong-Gon MoonSeock-Ah ImDong-Young Noh Clinical Trial 03 July 2012 Pages: 1133 - 1140
Lipid profiles within the SABRE trial of anastrozole with and without risedronate Catherine Van PoznakAndreas MakrisRichard Eastell Clinical Trial 05 July 2012 Pages: 1141 - 1147
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer Martin SchulerAhmad AwadaNadia Harbeck Clinical trial Open access 05 July 2012 Pages: 1149 - 1159
Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel–FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice Sonia PernasMiguel Gil-GilJosep Ramon Germà Clinical Trial 08 July 2012 Pages: 1161 - 1168
The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study Luca G. CampanaSara ValpioneCarlo R. Rossi Clinical trial 24 July 2012 Pages: 1169 - 1178
Impact of real-time virtual sonography, a coordinated sonography and MRI system that uses an image fusion technique, on the sonographic evaluation of MRI-detected lesions of the breast in second-look sonography Shogo NakanoJunko KousakaOsamu Arai Clinical Trial 24 July 2012 Pages: 1179 - 1188
Accuracy of BRCA1/2 mutation prediction models in Korean breast cancer patients Eunyoung KangSue K. ParkKorean Breast Cancer Society Epidemiology 22 March 2012 Pages: 1189 - 1197
Disparities in breast cancer mortality trends in a middle income country Ana Maria PedrazaMarina PollánAnna Cabanes Epidemiology 30 March 2012 Pages: 1199 - 1207
Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry Meghan E. WorkIrene L. AndrulisMary Beth Terry Epidemiology 25 April 2012 Pages: 1209 - 1220
Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institution E. BotteriO. GentiliniU. Veronesi Epidemiology 26 April 2012 Pages: 1221 - 1228
Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management Simone HeidemannChristine FischerNorbert K. Arnold Epidemiology 26 April 2012 Pages: 1229 - 1239
Tumour characteristics among women with very low-risk breast cancer S. A. NarodA. ValentiniW. Hanna Epidemiology 01 May 2012 Pages: 1241 - 1246
Cardiometabolic factors and breast cancer risk in U.S. black women Jaclyn L. F. BoscoJulie R. PalmerLynn Rosenberg Epidemiology 19 June 2012 Pages: 1247 - 1256
Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990–2008 Jennifer A. SchlichtingAmr S. SolimanSofia D. Merajver Epidemiology 26 June 2012 Pages: 1257 - 1268
Selenium intake and breast cancer mortality in a cohort of Swedish women Holly R. HarrisLeif BergkvistAlicja Wolk Epidemiology 27 June 2012 Pages: 1269 - 1277
Accelerometer-based measures of active and sedentary behavior in relation to breast cancer risk Cher M. DallalLouise A. BrintonGretchen L. Gierach Epidemiology 01 July 2012 Pages: 1279 - 1290
Association of sleep duration and breast cancer OncotypeDX recurrence score Cheryl L. ThompsonLi Li Epidemiology 03 July 2012 Pages: 1291 - 1295
Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women Matthew P. BanegasChristopher I. Li Epidemiology 08 July 2012 Pages: 1297 - 1304
Patterns of bone density evaluation in a community population treated with aromatase inhibitors Jennifer A. LigibelA. James O’MalleyNancy L. Keating Epidemiology 12 July 2012 Pages: 1305 - 1313
Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer Haeyoung KimDae-Yeon ChoBruce G. Haffty Epidemiology 14 July 2012 Pages: 1315 - 1326
The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors Meredith BockDan MooreMichelle Melisko Epidemiology 15 July 2012 Pages: 1327 - 1335
Mutational analysis of telomere genes in BRCA1/2-negative breast cancer families with very short telomeres Kira YanowskyAlicia BarrosoBeatriz Martinez-Delgado Brief Report 03 July 2012 Pages: 1337 - 1343
Letter in response: the value of mammography screening Robert C. BurtonRobin J. Bell Letter to the Editor 19 April 2012 Pages: 1345 - 1346
Comments on adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease Chun ZhangGuo-Qiang LvPing Zhou Letter to the Editor 10 July 2012 Pages: 1347 - 1348
Protective effect of longstanding lactation and reproductive factors: a case–control study in North Tanzania Ningqi HouDezheng HuoOlufunmilayo I. Olopade Invited Commentary 09 March 2011 Pages: 1349 - 1351